Edition:
United Kingdom

Catalyst Biosciences Inc (CBIO.OQ)

CBIO.OQ on NASDAQ Stock Exchange Capital Market

10.17USD
21 Sep 2018
Change (% chg)

$-0.23 (-2.21%)
Prev Close
$10.40
Open
$10.39
Day's High
$10.39
Day's Low
$9.91
Volume
93,132
Avg. Vol
126,391
52-wk High
$37.00
52-wk Low
$4.17

Chart for

About

Catalyst Biosciences, Inc., formerly Targacept, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on creating and developing medicines to address serious medical conditions. The Company focuses its product development efforts in the fields of hemostasis, including the treatment of hemophilia and... (more)

Overall

Beta: 1.35
Market Cap(Mil.): $24.57
Shares Outstanding(Mil.): 4.31
Dividend: --
Yield (%): --

Financials

  CBIO.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -17.82 -- --
ROI: -68.74 15.07 14.61
ROE: -83.55 16.59 16.33

BRIEF-Catalyst Biosciences Reports Q1 Loss Per Share $0.56

* CATALYST BIOSCIENCES REPORTS FIRST QUARTER OPERATING & FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

03 May 2018

BRIEF-Catalyst Biosciences Receives $1.5 Million For Neuronal Nicotinic Receptor Asset

* CATALYST BIOSCIENCES RECEIVES $1.5 MILLION IN TWO MILESTONE PAYMENTS FOR NEURONAL NICOTINIC RECEPTOR (NNR) ASSET Source text for Eikon: Further company coverage:

26 Mar 2018

Competitors

Earnings vs. Estimates